dr. hurvitz on novel agents in her2-positive breast cancer
Published 5 years ago • 458 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:55
dr. hurvitz on novel emerging agents in her2 breast cancer
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
9:37
novel treatments in her2-positive breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
1:03
dr. hurvitz on steps to take with her2-positive breast cancer research
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:58
dr. hurvitz discusses role of pertuzumab in her2 breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
1:54
her2 positive metastatic breast cancer treatment options explained
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
0:58
dr. hurvitz on treatment options for her2-positive breast cancer
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
1:13
dr. hurvitz on using adcs in her2 breast cancer
-
1:26
dr. hurvitz on unmet needs in her2 breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer